NR1H4 and esophageal adenocarcinoma: Several studies reported that decreased FXR expression leads to tumorigenic phenotypes in breast, bile duct, colon, liver, and intestine while there are also studies that support that the overexpression of FXR protein induces non-small cell lung cancer and esophageal cancer and esophageal adenocarcinoma [20,22–28].